Evidence map›Paper›PMID 39795899›Full record

ArticleInternational journal of molecular sciences2024

How Do Gepotidacin and Zoliflodacin Stabilize DNA-Cleavage Complexes with Bacterial Type IIA Topoisomerases? 2. A Single Moving Metal Mechanism.

Robert A Nicholls, Harry Morgan, Anna J Warren, Simon E Ward, Fei Long, Garib N Murshudov, Dmitry Sutormin, Benjamin D Bax

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Robert A NichollsScientific Computing Department, UKRI Science and Technology Facilities Council, Harwell Campus, Didcot, Oxfordshire OX11 0DE, UK.ORCID 0000-0002-8577-8617
Harry MorganMedicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK.ORCID 0000-0001-7349-1486
Anna J WarrenDiamond Light Source, Harwell Campus, Didcot, Oxfordshire OX11 0DE, UK.
Simon E WardMedicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK.ORCID 0000-0002-8745-8377
Fei LongMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.
Garib N MurshudovMRC Laboratory of Molecular Biology, Cambridge CB2 0QH, UK.ORCID 0000-0001-6483-3587
Dmitry SutorminInstitute for Systems Biology, Seattle, WA 98109, USA.ORCID 0000-0001-6834-4246
Benjamin D BaxMedicines Discovery Institute, Cardiff University, Cardiff CF10 3AT, UK.

Funding

Ada Lovelace Centre N/ABiotechnology and Biological Sciences Research Council BB/S007083/1Diamond Light Source N/AMedical Research Council MC_UP_A025_1012Medicines Discovery Institute, Cardiff N/AScience and Technology Facilities Council N/A
6 · The paper itself

Abstract

DNA gyrase is a bacterial type IIA topoisomerase that can create temporary double-stranded DNA breaks to regulate DNA topology and an archetypical target of antibiotics. The widely used quinolone class of drugs use a water-metal ion bridge in interacting with the GyrA subunit of DNA gyrase. Zoliflodacin sits in the same pocket as quinolones but interacts with the GyrB subunit and also stabilizes lethal double-stranded DNA breaks. Gepotidacin has been observed to sit on the twofold axis of the complex, midway between the two four-base-pair separated DNA-cleavage sites and has been observed to stabilize singe-stranded DNA breaks. Here, we use information from three crystal structures of complexes of

Indexed as

DNA CleavageDNA GyraseHeterocyclic Compounds, 3-RingOxazolidinonesAcenaphthenesAnti-Bacterial AgentsMagnesiumMetalsModels, MolecularStaphylococcus aureusTopoisomerase II InhibitorsAcenaphthenesAnti-Bacterial AgentsDNA GyrasegepotidacinHeterocyclic Compounds, 3-RingMagnesiumMetalsOxazolidinonesTopoisomerase II InhibitorsDNA-cleavagefluoroquinolonegepotidacinmoxifloxacinnovel bacterial topoisomerse inhibitor (NBTI)spirocyclic pyrimidine trione (SPT)type IIA topoisomerasezoliflodacin

Identifiers

PMID39795899
PMCPMC11720246

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.